Stay Informed on Corporate Sustainability

Author: Archie Villaflores

The pharmaceutical sector is driven by breakthroughs in research, leadership development, and integrated project delivery. In this edition, we examine how organisations are combining innovation, operational agility, and inclusive strategies to set new benchmarks across the industry. In review of a notable milestone from last year, ‘Pharmaceutical and Molecular Biotechnology Research Centre wins Research & Development Achievement Award at Pharma Industry Awards 2025’ marks a high point in ocular drug delivery and sustainability-led laboratory practices. The centre’s achievement sets the stage for 2026, emphasising the ongoing impact of R&D on industry standards and patient outcomes. Moreover, ‘BioPharmaChem Skillnet Launches Inclusive Leadership Programme for 2026’ demonstrates how targeted leadership development can shape a culture of inclusion and strategic thinking. The programme equips participants with actionable tools to influence team dynamics and foster innovation across pharmaceutical organisations. Meanwhile, ‘Partnering for Success: Tandem Delivers End-to-End Project Excellence in the Life Science Sector’ highlights how collaborative, client-focused approaches enhance project delivery across complex life science initiatives. Effective coordination and technical expertise ensure operational certainty while driving measurable outcomes. These stories underline a common thread: scientific excellence, inclusive leadership, and operational mastery are shaping the next wave of growth and impact in pharma.

Author: Jed Nykolle Harme

BioPharmaChem Skillnet launches its 2026 Inclusive Leadership Programme, blending practical workshops and personalised coaching to develop self-aware, inclusive leaders.

Author: Jed Nykolle Harme

Tandem Project Management delivers end-to-end project excellence for life science companies, combining technical expertise, regulatory compliance, and operational agility to drive innovation and measurable results.

Author: Jed Nykolle Harme

Applauded for its pioneering research in 2025, the Pharmaceutical and Molecular Biotechnology Research Centre won the Research & Development Achievement Award at the Pharma Industry Awards 2025, setting a benchmark as the sector looks toward 2026.

Author: Archie Villaflores

Vect-Horus and OliX Pharmaceuticals have launched a CNS-focused collaboration to evaluate siRNA delivery via blood-brain barrier shuttle technology. The partnership aims to accelerate RNAi-based therapeutics for hard-to-reach CNS targets.

Author: Archie Villaflores

Insilico Medicine has partnered with Qilu Pharmaceutical to develop cardiometabolic therapies using AI-driven small molecule design. The $120m deal includes development milestones, royalties, and potential out-licensing revenue exceeding $2bn.

Author: Archie Villaflores

Ireland’s largest pharmacy group McCabes Pharmacy has completed a company-wide digitisation programme covering auditing, stock monitoring, internal communications, and major projects. The strategy has improved compliance, efficiency, and asset protection across 110 stores.

Author: Archie Villaflores

Innovation, operational excellence, and workforce development continue to accelerate the pharmaceutical and life sciences sector. Organisations that combine technical expertise, strategic vision, and collaborative approaches are setting benchmarks for global impact and sustainable growth. In reflection on last year’s landmark success, ‘Viatris Little Island wins Pharma Project of the Year – Large at Pharma Industry Awards 2025’ highlights the precision and resilience required to deliver complex engineering projects in live production environments. That achievement reinforces how large-scale operational excellence can shape standards for high-impact pharmaceutical initiatives as the 2026 awards cycle approaches. Moreover, ‘SGS’s Expanding Role in Biopharma Quality, Safety, and Scientific Assurance Across Global Network’ illustrates how integrated scientific and regulatory expertise underpins global biopharma innovation. By supporting quality, safety, and compliance across diverse programmes, SGS is enabling companies to accelerate advanced therapies with confidence. Meanwhile, ‘UCC and BioPharmaChem Skillnet bring the future of biopharmaceuticals to learners’ reflects the growing importance of workforce development in emerging technologies. Providing accessible, advanced training ensures that the sector has the skills needed to meet next-generation medicine challenges. These stories underscore how operational leadership, scientific excellence, and talent development are shaping the future of global life sciences.

Author: Jed Nykolle Harme

Celebrated for its excellence last year, Viatris Little Island was named Pharma Project of the Year – Large at the Pharma Industry Awards 2025, setting a benchmark for complex pharma projects as the 2026 awards cycle approaches.

Author: Jed Nykolle Harme

SGS details how its global scientific and regulatory expertise supports quality and safety in advanced biopharma therapies, from development to commercialisation.